• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

环孢素A白蛋白纳米粒的制备、体外释放及大鼠药代动力学评价

张勇, 高敏姣, 张来芳, 霍美蓉, 彭晓玲, 周建平

张勇, 高敏姣, 张来芳, 霍美蓉, 彭晓玲, 周建平. 环孢素A白蛋白纳米粒的制备、体外释放及大鼠药代动力学评价[J]. 中国药科大学学报, 2013, 44(3): 239-243. DOI: 10.11665/j.issn.1000-5048.20130310
引用本文: 张勇, 高敏姣, 张来芳, 霍美蓉, 彭晓玲, 周建平. 环孢素A白蛋白纳米粒的制备、体外释放及大鼠药代动力学评价[J]. 中国药科大学学报, 2013, 44(3): 239-243. DOI: 10.11665/j.issn.1000-5048.20130310
ZHANG Yong, GAO Minjiao, ZHANG Laifang, HUO Meirong, PENG Xiaoling, ZHOU Jianping. Cyclosporine A-loaded albumin nanoparticles:preparation, in vitro release and evaluation of pharmacokinetics in rats[J]. Journal of China Pharmaceutical University, 2013, 44(3): 239-243. DOI: 10.11665/j.issn.1000-5048.20130310
Citation: ZHANG Yong, GAO Minjiao, ZHANG Laifang, HUO Meirong, PENG Xiaoling, ZHOU Jianping. Cyclosporine A-loaded albumin nanoparticles:preparation, in vitro release and evaluation of pharmacokinetics in rats[J]. Journal of China Pharmaceutical University, 2013, 44(3): 239-243. DOI: 10.11665/j.issn.1000-5048.20130310

环孢素A白蛋白纳米粒的制备、体外释放及大鼠药代动力学评价

基金项目: 国家自然科学基金资助项目( No. 81102397);国家“重大新药创制”科技重大专项资助项目( No.2009ZX09310-004)

Cyclosporine A-loaded albumin nanoparticles:preparation, in vitro release and evaluation of pharmacokinetics in rats

  • 摘要: 以人血白蛋白为载体,制备环孢素A白蛋白纳米粒(CyA-HSA),考察其包封率、载药量、粒径、Zeta电位、pH、渗透压、形态、稀释稳定性等理化性质,并以透析法研究其体外释药特性。结果表明,所制得的CyA-HSA纳米粒载药量为14.7%,包封率为85.8%,动态光散射法测定其粒径为240.5 nm,Zeta电位为-32.0 mV,pH为7.0,渗透压为314.7 mOsmol/kg。透射电镜照片表明该纳米体系为规整的球形结构。CyA-HSA纳米制剂比市售环孢素A注射剂(山地明)具有更优越的稀释稳定性,且二者皆具有缓释特性,并呈现零级释药特征。CyA-HSA和山地明注射剂同剂量(7 mg/kg)静脉注射后,二者体内过程均符合二房室模型,与山地明注射剂相比,CyA-HSA的药物清除率和药物从中央室的消除速率常数k10均有显著下降,AUC显著提高(P<;0.05)。HSA 纳米粒能够高效负载CyA,同时克服了山地明注射剂中增溶剂(聚氧乙烯蓖麻油)的不良反应,有望开发成为环孢素的新一代制剂。
    Abstract: Cyclosporine A-loaded human serum albumin nanoparicles(CyA-HSA)were prepared and physicochemical properties including entrapment efficiency, drug-loading capability, particles size, Zeta potential, morphology, pH value and osmotic pressure were evaluated. Dialysis was undertaken to investigate the release of CyA from CyA-HSA nanoparticles in vitro. The obtained CyA-HSA nanoparticles showed spherical shape with mean particle sizes of 240. 5 nm and Zeta potential of -32. 0 mV. The drug-loading amount and entrapment efficiency were 14. 7% and 85. 8%, respectively. The pH and osmotic pressure of nanoparticles were 7. 0 and 314. 7 mOsmol/kg, respectively. CyA-HSA nanoparticles exhibited better dilution stability than commercial cyclosporine A injection, Sandimmune® . Both CyA-HSA and Sandimmune® exhibited significant sustained release behavior in vitro and both release profiles displayed a zero-order process. The pharmacokinetic study at equal administration dosage(7 mg/kg)in rats showed that cyclosporine A concentration-time data were in accordance with the two-compartment model. The CL and k10 of CyA-HSA significantly decreased and AUC significantly increased compared to those of Sandimmune® (P< 0. 05). CyA-HSA nanoparticles showed obvious solubility enhancement, sustained release and less side effect and toxicity resulting from solubilizing agent of Sandimmune® , Cremophor EL, and might be developed as the next generation dosage form of cyclosporine A.
计量
  • 文章访问数:  1353
  • HTML全文浏览量:  1
  • PDF下载量:  2729
  • 被引次数: 0
出版历程
  • 刊出日期:  2013-06-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭